research grant from Astellas, Bayer, Boehringer Ingelheim Japan, Fuji, Mochida, and Novartis
Can a lactating woman safely use GLP1 receptor agonists (e.g., exenatide, liraglutide, dulaglutide, semaglutide) while breastfeeding?
For each primer set, a generalized additive model (GAM) was fitted over the log2-transformed normalized gene expression values using the R-package mgcv v1.837 (Wood 2011)
Athletes should also be aware that BPC-157 is named under WADAs prohibited-substance framework, while thymosin beta-4 and related growth-factor or regenerative substances may raise additional anti-doping concerns
The synthesis of dendrimers typically follows either a divergent or convergent approach
10.1038/s41514-024-00135-7 38 Luna-MarcoC.de MaraonA